Literature DB >> 9627285

Elevated levels of basal estradiol-17beta predict poor response in patients with normal basal levels of follicle-stimulating hormone undergoing in vitro fertilization.

J L Evers1, P Slaats, J A Land, J C Dumoulin, G A Dunselman.   

Abstract

OBJECTIVE: To evaluate whether the predictive ability of a normal FSH level on cycle day 3 can be enhanced by levels of estradiol-17beta (E2) on cycle day 3.
DESIGN: Prospective cohort study.
SETTING: University hospital-based, tertiary care infertility center. PATIENT(S): Two hundred thirty-one consecutively seen patients who attended the center for their first IVF attempt. INTERVENTION(S): Blood samples were collected on day 3 of the cycle preceding IVF; IVF was performed in all patients. MAIN OUTCOME MEASURE(S): Patient's age, number of ampules of hMG, cancellation rate, number of oocytes, fertilization rate, and clinical pregnancy rate. RESULT(S): In patients with elevated FSH levels on cycle day 3, a low oocyte yield was achieved (7 versus 11) and a high number of ampules of hMG was necessary (56 versus 33). Their cancellation rate was high (67% versus 16%). In patients with normal basal FSH levels, high E2 levels predicted a high cancellation rate (56%, versus 13% in patients with low E2 levels) and a low oocyte yield (9, versus 11 in patients with low E2 levels). Patients with both normal FSH levels and low E2 levels on cycle day 3 fared best. CONCLUSION(S): The basal E2 level on cycle day 3 is a useful prognosticator of response to stimulation in IVF patients with normal basal FSH levels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9627285     DOI: 10.1016/s0015-0282(98)00080-6

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  11 in total

1.  Body mass index, follicle-stimulating hormone and their predictive value in in vitro fertilization.

Authors:  Kathrin Ferlitsch; Michael O Sator; Doris M Gruber; Ernst Rücklinger; Christian J Gruber; Johannes C Huber
Journal:  J Assist Reprod Genet       Date:  2004-12       Impact factor: 3.412

Review 2.  Ovarian reserve evaluation: state of the art.

Authors:  Bruno Ramalho de Carvalho; Ana Carolina Japur de Sá Rosa e Silva; Júlio César Rosa e Silva; Rosana Maria dos Reis; Rui Alberto Ferriani; Marcos Felipe Silva de Sá
Journal:  J Assist Reprod Genet       Date:  2008-08-05       Impact factor: 3.412

3.  The effect of smoking on oocyte quality and hormonal parameters of patients undergoing in vitro fertilization-embryo transfer.

Authors:  M Weigert; G Hofstetter; D Kaipl; H Gottlich; U Krischker; K Bichler; M Poehl; W Feichtinger
Journal:  J Assist Reprod Genet       Date:  1999-07       Impact factor: 3.412

4.  IVF performance of women who have fluctuating early follicular FSH levels.

Authors:  A Lass; A Gerrard; N Abusheikha; F Akagbosu; P Brinsden
Journal:  J Assist Reprod Genet       Date:  2000-11       Impact factor: 3.412

5.  The practical implications of a raised serum FSH and age on the risk of IVF treatment cancellation due to a poor ovarian response.

Authors:  Valentine A Akande; Stephen D Keay; Linda P Hunt; Rajneesh S Mathur; Julian M Jenkins; David J Cahill
Journal:  J Assist Reprod Genet       Date:  2004-07       Impact factor: 3.412

6.  Vasomotor symptoms in infertile premenopausal women: a hitherto unappreciated risk for low bone mineral density.

Authors:  Lubna Pal; John Norian; Gohar Zeitlian; Kris Bevilacqua; Ruth Freeman; Nanette Santoro
Journal:  Fertil Steril       Date:  2008-02-20       Impact factor: 7.329

7.  When is clomiphene or gonadotropin intrauterine insemination futile? Results of the Fast Track and Standard Treatment Trial and the Forty and Over Treatment Trial, two prospective randomized controlled trials.

Authors:  Daniel J Kaser; Marlene B Goldman; June L Fung; Michael M Alper; Richard H Reindollar
Journal:  Fertil Steril       Date:  2014-09-16       Impact factor: 7.329

8.  Ovarian reserve tests.

Authors:  Padma Rekah Jirge
Journal:  J Hum Reprod Sci       Date:  2011-09

9.  Poor responders in in vitro fertilization (IVF) therapy: the challenge continues.

Authors:  S Oehninger
Journal:  Facts Views Vis Obgyn       Date:  2011

Review 10.  The meaning of anti-Müllerian hormone levels in patients at a high risk of poor ovarian response.

Authors:  Hyun Jong Park; Geun Ho Lee; Du Sik Gong; Tae Ki Yoon; Woo Sik Lee
Journal:  Clin Exp Reprod Med       Date:  2016-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.